Manuscript Submission – Author Instructions
JOURNAL DESCRIPTION, AIM and SCOPE
The Journal of Food Allergy (JFA) is a peer reviewed, open access publication which publishes under the Creative Commons License: (Attribution – Non-Commercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). JFA is dedicated to distributing timely information regarding cutting edge advancements in food allergy. Its primary readership extends to all medical professionals with a particular interest in the science and medicine of food allergy. JFA seeks to publish articles characterized by a predominant clinical focus and by having the potential to directly impact the quality of patient care. JFA welcomes the submission of original works including peer-reviewed original research and clinical trial results.
JFA advises that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below, then visit the Journal’s submission site to upload your manuscript and required publication forms. Upon submission of your manuscript it will immediately be sent to the editorial board for rapid screening; only manuscripts of sufficient quality that are consistent with the JFA aim and scope (described above) will advance to the formal peer review process. Additionally, please note that manuscripts which do not conform to the manuscript submission guidelines (outlined below) will be returned to the author(s) for revision prior to initiation of peer review. Please contact the editorial offices with any questions regarding the submission process.
MANUSCRIPT SUBMISSION GUIDELINES
JFA utilizes an online system for manuscript submission and peer review. This system allows authors to submit their work electronically and to check on the status of the review process. To access the electronic system, visit http://jfa.msubmit.net. This technology requires all manuscript files to be uploaded separately as follows:
- cover letter
- manuscript (including title page, abstract, text, references and figure legends only) excluding table and figure files
- tables (can be consolidated into one “tables” file or uploaded separately)
- figures (preferably uploaded separately)
- Publication Forms
- publication rights agreement
- conflict of interest
It is an important prerequisite that the Publication Rights Agreement and Conflict of Interest forms be submitted (uploaded) in order to be considered for peer review. Please download blank forms here and submit completed forms via electronic transmission, email or fax. To submit electronically, please visit the submission site and upload under the manuscript submission page (http://jfa.msubmit.net) Blank forms are available at: http://jfoodallergy.com/
Electronic manuscript submission is a four-step process that is described step-by-step at www.jfa.msubmit.net. JFA does not accommodate the submission of paper manuscripts.
SELECTING A MANUSCRIPT TYPE: When uploading your completed manuscript, you will be required to designate a manuscript type. The following are guidelines for choosing:
- Solicited Meeting paper: (Restricted to solicited/invited manuscripts) If the solicited manuscript was written based upon an invitation to present information at a specific conference, please select this manuscript type. Components indicated by a checkmark below should appear in the order they are presented here (i.e. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures). The corresponding scientific meeting should be included on the title page in the format of the name of the meeting, city, state (or country), date of meeting. i.e. “Presented at the “ABC” Conference, City, State, (Date) September 7, 2018”. Word limit: 3,000 words
- Original manuscript: Defined as papers which provide the results of original laboratory and/or clinical research. Components indicated by a checkmark below should appear in the order they are presented here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures). Word Limit: 2500 words (exceptions allowed under special circumstances)
- Review: Defined as a manuscript that provides a systematic review of previously published literature. Systematic reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively. Components indicated below should appear in the order they are presented here (ie. title page, abstract, manuscript, text, acknowledgment, references, figure legends, tables, figures).Please refer to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for guidance: www.prisma-statement.org Word limit: 3000 words
- Short Communication: An original manuscript that has a limit of 2000 words in length, (approx. 4 pages, figure and table count 200 words each) and with no more than 20 references. Components indicated by a checkmark below should appear in the order they are presented here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures)
- Letters to the Editor: Letters are limited to brief communications which specifically relate to a recently published article in the Journal. Letters to the editor will be reviewed by the Editor(s) and responded to by the author(s) of the referenced article. Letters to the Editor are limited to 500 words and 5 references. As letters to the editor are indexed and cited like original articles, key words are also required. Letters to the Editor will be published exclusively online, with exceptions per the Editor
- Case Reports: Except by invitation, the JFA does not encourage the submission of case reports.
- Expedited Manuscript Service (EMS): This is a fee-based option requiring the EMS Request Form. The EMS option is for authors who consider the publication of their manuscripts to be time sensitive or who have specific publication deadlines to meet. EMS expedites both the peer review process and the publication date of accepted manuscripts See Author Instructions for more information.
Cover letter: The cover letter should declare the authors’ intentions to publish in the JFA and confirm that the manuscript has not been submitted elsewhere
- Relevant and concise (no more than 15 words) title in sentence format (only capitalize proper nouns). Do not include abbreviations or use trade names in the title.
- First name, middle initial, last name of each author with highest academic degrees included (do not include fellowships). All contributing authors should be listed including any professional writing assistance.
- Name of Departments and Institutions to which work should be attributed; (see Conflict of Interest below)
- Disclaimers and disclosures, if any, should be limited to those pertaining to this work. Please reconcile conflicts of interest for each author to match those submitted with each conflict of interest form.
- If this work is supported through NIH funding, this must be noted in the footnote for PMC deposit
- Acknowledgment of Financial Support/Funding. (see Conflict of Interest below)
- As per ICMJE guidelines (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html), in studies involving human subjects, or human derived data, it is required that a statement describing approval by the Institutional Review Board (IRB), including the full name of the institution which provided the IRB approval and the approval number if available. This IRB statement as well as statements regarding Informed Consent and/or animal rights should be included in the methods section of the manuscript.
- Key Words: (10 key words are mandatory) selecting appropriate key words is essential to your research being discovered by others.
- Include date and location of presentation at scientific meeting (if any)
- Include corresponding author’s email address and telephone number.
Abstract: All manuscript types with the exception of the Letters to the Editors should include a structured abstract, no longer than 300 words, to precede article. Only include acronyms or abbreviations if the phrase appears more than three times in the abstract. The abstract should NOT contain brand names, trademarks or references. Clinical trial registration numbers should be listed at the end of the abstract. Structure abstract into the following sections:
- Background – Describe the problem that prompted the study
- Objective – Describe the purpose of the study
- Methods – Describe how the study was conducted
- Results – Describe the most important findings
- Conclusion – Describe the most important conclusion drawn from the study
Text: Specified length for all manuscript types listed above do not include abstract and references. Please insert line numbers into text for the ease of peer review. Manuscript should be typed double-spaced in a standard font such as Times New Roman, Arial, Courier, or Helvetica, in size 12. Text should be written in clear and concise English.
- Authors whose primary language is not English should obtain assistance with writing to avoid grammatical issues. Several independent services for STM authors are available online and include:
|Asia Pacific India:||www.asiascienceediting.com/|
Please note: These few sites are only listed as a convenience and are not an endorsement of their products. They are in no way affiliated with the journal and use of their services will not guarantee acceptance of a manuscript.
Acknowledgment: General acknowledgments for consultations, statistical analysis and such should be listed at the end of the text before the References. Include full names of individuals. This section is not for disclosures of conflicts of interest. Any and all acknowledgments of funding must be disclosed on the title page.
References: Vancouver style with modification. Refer to EndNote/OceanSide Publications for proper reference structure. References in the text should be superscript numbers in order of appearance. Manuscripts in preparation, personal communications, or other unpublished information should not be cited in the reference list but may be mentioned in the text in parentheses. References with more than three authors should be presented as the first three authors followed by et al. (Endnote.com/downloads/styles) Please follow format below, e.g.:
- Settipane RA. A Journal with a precise purpose. J Food Allergy. 2019; 1:1.
Tables: Tables may be placed within the manuscript or uploaded as separate files (in .doc format). If tables are included in manuscript file, insert after the References section, one table per page. Any abbreviations included in the table should be defined in the table legend. If the table is being republished with permission, proof of permission must be transmitted to the editorial office.
Figure legends: Figure legends should be typewritten, double-spaced and listed (numbered) on a separate page after the tables. Legends should not appear as a component of the figures. Include figure titles at the beginning of the legend. Any abbreviations included in the figures should be defined in the figure legend.
Figures and illustrations: Illustrations included in manuscripts must be submitted in electronic format along with the rest of the manuscript. Each figure should be uploaded individually as a separate electronic file(s) – not imbedded in the manuscript text file. See Cadmus guidelines for submitting digital art at http://cpc.cadmus.com/da/guidelines.asp. Figure file preference is .tif, .jpeg, .eps. Proof of permission must be transmitted to the editorial office for any figures being republished with permission. Proof of informed consent (signed releases) must be transmitted to the editorial office for any and all photographs of identifiable persons. If the authors have included any copyrighted figures in their manuscript, it is the responsibility of the author to obtain the necessary rights/permissions from the copyright holder.
Publication Rights Agreement: MANUSCRIPTS WILL NOT BE REVIEWED UNLESS ACCOMPANIED BY AN EXECUTED PUBLICATION RIGHTS AGREEMENT SIGNED BY THE AUTHOR(S). The agreement warrant(s) that the article is original, does not infringe upon any copyright or other proprietary right of any third party, is not under consideration by another journal, and has not been previously published. The author(s) confirm that they have reviewed and approved the final version of the manuscript. Items are accepted for publication on the understanding that they are contributed solely to the Journal of Food Allergy (JFA) and have not been or will not be published elsewhere in any format except in abstract form. Blank publication forms should be downloaded at http://jfoodallergy.com, completed and uploaded with your submission.
Conflict of Interest form (per ICJME guidelines): JFA requires all authors listed on the title page of the manuscript to make the following disclosures:
- On the title page of the manuscript, authors must acknowlede a. all funding sources that supported their work and b. all institutional or corporate affiliations of each author
- Also, per ICJME guidelines, all authors must submit a separate form (one for each author) listing the existence of any and all commercial associations that might pose a conflict of interest such as: consultant arrangements, advisory boards, speaker bureaus, research grants, stock or other equity ownership, patent licensing arrangements, or payments for conducting or publicizing the study. MANUSCRIPTS WILL NOT BE REVIEWED UNLESS ACCOMPANIED BY A CONFLICT OF INTEREST DISCLOSURE FORM SIGNED BY EACH AND EVERY AUTHOR. Disclosures will be held in strict confidence during the review process. However, if the paper is accepted for publication, the Editor will determine how any conflict of interest should be disclosed. Download blank Conflict of Interest forms at http://jfoodallergy.com and upload this form with your manuscript files.
JOURNAL STATEMENTS AND POLICIES:
JFA adheres to the following policies etablished by its publisher, Oceanside Publications, Inc. Please review these Statements and Policies.